Jacek Kociszewski
Research Subjects
Jacek Kociszewski has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
V. Viereck
Department of Gynecology and Obstetrics, Cantonal Hospital, Pfaffenholzstraße 4, 8501 Frauenfeld, Switzerland
2 shared publicationsA. Wiedemann
Universität Witten/Herdecke
1 shared publication- Andreas Wiedemann
Urologische Klinik, Evangelisches Krankenhaus Witten im Diakoniewerk Ruhr gGmbH
1 shared publication Andrzej Kuszka
Department of Obstetrics and Gynecology, Lutheran Hospital Hagen-Haspe, Germany
1 shared publication- Andrzej Pomian
Department of Obstetrics and Gynecology, Multidisciplinary Hospital Warsaw-Miedzylesie, 04-749 Warsaw, Poland
1 shared publication - Aneta Zwierzchowska
1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 28 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (5) , 1377
Current Treatment of Stress Urinary Incontinence by Bulking Agents and Laser Therapy—An Update
Stress urinary incontinence (SUI) affects around 20% of women. In addition to the established suburethral sling insertion, two less invasive approaches are of interest today: urethral bulking agents and vaginal laser therapy. This review discusses articles through December 2023 identified by a PubMed literature search using the keywords “incontinence” and “bulking” or “laser”. Although the two approaches are less effective than sling insertions, there are specific conditions in which one or the other technique is more advantageous. Injecting bulking agents into the urethra only takes some minutes and works without general anesthesia. The method is particularly suited for elderly, frail, or obese patients with multiple comorbidities, but is also applicable for all patients and in combination with other therapies. Generally, the safety profile is good but differs between bulking materials. Two laser types—the Erbium:YAG laser with SMOOTH-mode and the fractional ablative CO2 laser—deliver heat into the tissue to induce tissue tightening and regeneration. Intravaginal laser therapy improves mild to moderate SUI, while studies describe how intraurethral laser therapy is also beneficial for severe SUI. Young women between childbirths, as well as postmenopausal women, may benefit from laser therapy. The method is safe, can be performed on an outpatient basis, and does not require any artificial material.
- 28 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (5) , 1377
Open AccessCurrent Treatment of Stress Urinary Incontinence by Bulking Agents and Laser Therapy—An Update
Stress urinary incontinence (SUI) affects around 20% of women. In addition to the established suburethral sling insertion, two less invasive approaches are of interest today: urethral bulking agents and vaginal laser therapy. This review discusses articles through December 2023 identified by a PubMed literature search using the keywords “incontinence” and “bulking” or “laser”. Although the two approaches are less effective than sling insertions, there are specific conditions in which one or the other technique is more advantageous. Injecting bulking agents into the urethra only takes some minutes and works without general anesthesia. The method is particularly suited for elderly, frail, or obese patients with multiple comorbidities, but is also applicable for all patients and in combination with other therapies. Generally, the safety profile is good but differs between bulking materials. Two laser types—the Erbium:YAG laser with SMOOTH-mode and the fractional ablative CO2 laser—deliver heat into the tissue to induce tissue tightening and regeneration. Intravaginal laser therapy improves mild to moderate SUI, while studies describe how intraurethral laser therapy is also beneficial for severe SUI. Young women between childbirths, as well as postmenopausal women, may benefit from laser therapy. The method is safe, can be performed on an outpatient basis, and does not require any artificial material.
- Open Access
- 18 December 2017
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (6) , 1653-1658
Is Bariatric Surgery a Prophylaxis for Pelvic Floor Disorders?
Introduction Obesity is one of the well-documented risk factors of pelvic floor disorders (PFDs). The PFDs include urinary and fecal incontinence (UI, FI) and pelvic organ prolapse (POP). Surgery-induced weight loss improves different kinds of incontinence as well as POP symptoms. However, there is a lack of evidence how bariatric surgery influences pelvic floor anatomy and function in women without previous PFDs and whether it may be concerned as PFD prophylaxis tool. Materials and Methods The present analysis is a prospective, non-randomized case-control study from January 2014 to September 2017. Participants underwent pelvic floor ultrasound examination with bladder neck position estimation at rest, during levator ani tension, and at Valsalva maneuver before surgery and 12–18 months after. Pelvic organ prolapse quantification (POPQ) > 2 stage and PFD complaints were the exclusion criteria. Results Fifty-nine patients underwent bariatric surgery (57 sleeve gastrectomy and 2 gastric bypass). Mean BMI decreased from 43.8 ± 5.9 to 29 ± 4.6 kg/m2 after surgery (p < 0.001). Statistically significant higher position of the bladder neck at rest, during tension, and at Valsalva maneuver (p < 0.05) was shown after surgery. We did not demonstrate differences in bladder neck mobility and bladder neck elevation at tension after weight loss. Conclusions Bariatric surgery is associated with a betterment of bladder neck position at rest, tension, and Valsalva maneuver in women without PFDs. We postulate that bariatric surgery may be a tool for PFD prevention. It does not improve levator ani function and does not limit bladder neck mobility, which implicates that it has no influence on preexisting pelvic dysfunction.
- 18 December 2017
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (6) , 1653-1658
Open AccessIs Bariatric Surgery a Prophylaxis for Pelvic Floor Disorders?
Introduction Obesity is one of the well-documented risk factors of pelvic floor disorders (PFDs). The PFDs include urinary and fecal incontinence (UI, FI) and pelvic organ prolapse (POP). Surgery-induced weight loss improves different kinds of incontinence as well as POP symptoms. However, there is a lack of evidence how bariatric surgery influences pelvic floor anatomy and function in women without previous PFDs and whether it may be concerned as PFD prophylaxis tool. Materials and Methods The present analysis is a prospective, non-randomized case-control study from January 2014 to September 2017. Participants underwent pelvic floor ultrasound examination with bladder neck position estimation at rest, during levator ani tension, and at Valsalva maneuver before surgery and 12–18 months after. Pelvic organ prolapse quantification (POPQ) > 2 stage and PFD complaints were the exclusion criteria. Results Fifty-nine patients underwent bariatric surgery (57 sleeve gastrectomy and 2 gastric bypass). Mean BMI decreased from 43.8 ± 5.9 to 29 ± 4.6 kg/m2 after surgery (p < 0.001). Statistically significant higher position of the bladder neck at rest, during tension, and at Valsalva maneuver (p < 0.05) was shown after surgery. We did not demonstrate differences in bladder neck mobility and bladder neck elevation at tension after weight loss. Conclusions Bariatric surgery is associated with a betterment of bladder neck position at rest, tension, and Valsalva maneuver in women without PFDs. We postulate that bariatric surgery may be a tool for PFD prevention. It does not improve levator ani function and does not limit bladder neck mobility, which implicates that it has no influence on preexisting pelvic dysfunction.
- Open Access
- 20 April 2015
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-5
Complications following Tension-Free Vaginal Tapes: Accurate Diagnosis and Complications Management
The sling procedures are the gold standard for SUI treatment. They are highly effective but not free from complications. The most common adverse effect for the surgery with the implant insertion is: overactive bladder occurring de novo after the surgery, voiding dysfunctions, urine retention, and unsatisfactory treatment outcome. The most important question that arises after 20 years of sling procedures is how to manage the complications and what can be offered to complicated patients. The above review summarises the ultrasound findings in complicated cases and shows the scheme of management of the clinical problems concerning the tape location in suburethral region.
- 20 April 2015
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-5
Open AccessComplications following Tension-Free Vaginal Tapes: Accurate Diagnosis and Complications Management
The sling procedures are the gold standard for SUI treatment. They are highly effective but not free from complications. The most common adverse effect for the surgery with the implant insertion is: overactive bladder occurring de novo after the surgery, voiding dysfunctions, urine retention, and unsatisfactory treatment outcome. The most important question that arises after 20 years of sling procedures is how to manage the complications and what can be offered to complicated patients. The above review summarises the ultrasound findings in complicated cases and shows the scheme of management of the clinical problems concerning the tape location in suburethral region.
- 30 August 2014
- Published by Wiley in Neurourology and Urodynamics
- Vol. 34 (8) , 741-746
Do different vaginal tapes need different suburethral incisions? The one-half rule
Aim Despite a wide array of vaginal tapes to treat stress urinary incontinence (SUI), evidence suggesting that both patient characteristics and tape positioning influence outcomes, and differing tape insertion pathways (retropubic vs. transobturator), it remains unclear if the same incision location is effective for all tapes. The aim of the study was to compare outcomes using two different surgical incision locations when inserting a transobturator vaginal tape (TOT) to treat SUI. Methods We compared patient characteristics, tape positioning, and surgical outcomes in 123 women undergoing a TOT procedure who were randomly assigned to have the surgical incision begin at 1/3 of the sonographically‐measured urethral length (similar to the traditional retropubic approach) or 1/2 of the urethral length. Results It was feasible to place the tape according to intention in 99.2% of the study cohort. The overall cure rate was higher when the incision site began at 1/2 the urethral length (83.6%) than 1/3 (62.9%) (P = 0.01). In the subgroup analyses, only patients with normal urethral mobility had significantly different cure rates (85.7% vs. 55.2%, P = 0.02). No significant differences in cure rates were observed between the other mobility categories of the study groups—hypermobility was consistently associated with high cure rates and hypomobility with low cure rates. Conclusions When surgically treating SUI with a TOT, incision at the mid‐urethra using the 1/2 rule is recommended as it leads to better outcomes for most patients, particularly those with normal urethral mobility. Neurourol. Urodynam.
- 30 August 2014
- Published by Wiley in Neurourology and Urodynamics
- Vol. 34 (8) , 741-746
Do different vaginal tapes need different suburethral incisions? The one-half rule
Aim Despite a wide array of vaginal tapes to treat stress urinary incontinence (SUI), evidence suggesting that both patient characteristics and tape positioning influence outcomes, and differing tape insertion pathways (retropubic vs. transobturator), it remains unclear if the same incision location is effective for all tapes. The aim of the study was to compare outcomes using two different surgical incision locations when inserting a transobturator vaginal tape (TOT) to treat SUI. Methods We compared patient characteristics, tape positioning, and surgical outcomes in 123 women undergoing a TOT procedure who were randomly assigned to have the surgical incision begin at 1/3 of the sonographically‐measured urethral length (similar to the traditional retropubic approach) or 1/2 of the urethral length. Results It was feasible to place the tape according to intention in 99.2% of the study cohort. The overall cure rate was higher when the incision site began at 1/2 the urethral length (83.6%) than 1/3 (62.9%) (P = 0.01). In the subgroup analyses, only patients with normal urethral mobility had significantly different cure rates (85.7% vs. 55.2%, P = 0.02). No significant differences in cure rates were observed between the other mobility categories of the study groups—hypermobility was consistently associated with high cure rates and hypomobility with low cure rates. Conclusions When surgically treating SUI with a TOT, incision at the mid‐urethra using the 1/2 rule is recommended as it leads to better outcomes for most patients, particularly those with normal urethral mobility. Neurourol. Urodynam.
- 18 September 2013
- Published by Springer Nature in Der Urologe
- Vol. 53 (1) , 55-61
„Tethered tape“ oder der 4. Faktor
- 18 September 2013
- Published by Springer Nature in Der Urologe
- Vol. 53 (1) , 55-61
„Tethered tape“ oder der 4. Faktor
- 25 May 2012
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 43 (03) , 144
Der "Hegar-Test" erleichtert das Auffinden eines dystopen suburethralen Bandes
Häufig ist das intraoperative Lokalisieren eines dystopen, obstruktiv wirkenden oder in die Harnröhre arrodierten TVT- oder TOT-Bandes schwierig. Hier hat sich ein einfacher Trick bewährt, um aufwendige, teilweise traumatisierende Präparationen zu vermeiden. Meist gelingt die ungefähre Ortung des TVT- oder TOT-Bandes mit der Introitus-Sonografie. Bei der Freilegung vor der Banddurchtrennung oder –resektion ist es jedoch oft schwierig, Kontakt zum Band herzustellen. Um die Palpation zu erleichtern, wird die Harnröhre mit einem Hegarstift armiert und nach kontralateral und kaudal angespannt: zur Lokalisation des rechten Schenkels nach 5 Uhr bzw. des linken Schenkels nach 7 Uhr. Der palpierende Finger der anderen Hand kann nun im "Spiel" des Hegar-Stiftes zwischen "locker" und "gespannt" das Band als derbe, querverlaufende Struktur tasten. Ggf. gelingt es sogar, das Band derart angespannt ohne Freipräparation mit einem Messer durch die Vaginalwand zu durchtrennen. Der Erfolg lässt sich sofort mit dem "Hegar-Test" kontrollieren: Wurde das Band komplett durchtrennt, kann es nicht mehr getastet werden. Dr. Andreas Wiedemann, Witten Dr. Jacek Kociszewski, Hagen
- 25 May 2012
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 43 (03) , 144
Der "Hegar-Test" erleichtert das Auffinden eines dystopen suburethralen Bandes
Häufig ist das intraoperative Lokalisieren eines dystopen, obstruktiv wirkenden oder in die Harnröhre arrodierten TVT- oder TOT-Bandes schwierig. Hier hat sich ein einfacher Trick bewährt, um aufwendige, teilweise traumatisierende Präparationen zu vermeiden. Meist gelingt die ungefähre Ortung des TVT- oder TOT-Bandes mit der Introitus-Sonografie. Bei der Freilegung vor der Banddurchtrennung oder –resektion ist es jedoch oft schwierig, Kontakt zum Band herzustellen. Um die Palpation zu erleichtern, wird die Harnröhre mit einem Hegarstift armiert und nach kontralateral und kaudal angespannt: zur Lokalisation des rechten Schenkels nach 5 Uhr bzw. des linken Schenkels nach 7 Uhr. Der palpierende Finger der anderen Hand kann nun im "Spiel" des Hegar-Stiftes zwischen "locker" und "gespannt" das Band als derbe, querverlaufende Struktur tasten. Ggf. gelingt es sogar, das Band derart angespannt ohne Freipräparation mit einem Messer durch die Vaginalwand zu durchtrennen. Der Erfolg lässt sich sofort mit dem "Hegar-Test" kontrollieren: Wurde das Band komplett durchtrennt, kann es nicht mehr getastet werden. Dr. Andreas Wiedemann, Witten Dr. Jacek Kociszewski, Hagen